# FDA Inspection 1231825 - Erode Cancer Centre - November 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/erode-cancer-centre/286c4388-daec-4f68-a188-fa7cde16104d
Source feed: FDA_Inspections

> FDA Inspection 1231825 for Erode Cancer Centre on November 21, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231825
- Company Name: Erode Cancer Centre
- Inspection Date: 2023-11-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1121547 - 2020-02-28](https://www.keypedia.com/records/fda_inspections/erode-cancer-centre/259befa6-1b75-4a97-8c65-fca6cd14c00e)

Company: https://www.keypedia.com/companies/erode-cancer-centre/8d952bcb-5a81-4637-9f8f-55b3c4c600d6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c